In some rare cases (regions with poor mapping quality), the ALT nucleotide listed in the GATK output is not the same in the tumor and normal samples. Now skipping those sites.
In some rare cases (regions with poor mapping quality), the ALT nucleotide listed in the GATK output is not the same in the tumor and normal samples. Now skipping those sites.